Angiotensin II receptor I auto-antibodies following SARS-CoV-2 infection

<h4>Background</h4> Coronavirus disease 2019 (COVID-19) is associated with endothelial activation and coagulopathy, which may be related to pre-existing or infection-induced pro-thrombotic autoantibodies such as those targeting angiotensin II type I receptor (AT1R-Ab). <h4>Methods&...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Yonghou Jiang, Fergal Duffy, Jennifer Hadlock, Andrew Raappana, Sheila Styrchak, Ingrid Beck, Fred D. Mast, Leslie R. Miller, William Chour, John Houck, Blair Armistead, Venkata R. Duvvuri, Winnie Yeung, Micaela Haglund, Jackson Wallner, Julie A. Wallick, Samantha Hardy, Alyssa Oldroyd, Daisy Ko, Ana Gervassi, Kim M. Murray, Henry Kaplan, John D. Aitchison, James R. Heath, D. Noah Sather, Jason D. Goldman, Lisa Frenkel, Whitney E. Harrington
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/cd573774925a43b6bf26a92fa1b1734f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:cd573774925a43b6bf26a92fa1b1734f
record_format	dspace
spelling	oai:doaj.org-article:cd573774925a43b6bf26a92fa1b1734f2021-11-25T06:19:45ZAngiotensin II receptor I auto-antibodies following SARS-CoV-2 infection1932-6203https://doaj.org/article/cd573774925a43b6bf26a92fa1b1734f2021-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598062/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4> Coronavirus disease 2019 (COVID-19) is associated with endothelial activation and coagulopathy, which may be related to pre-existing or infection-induced pro-thrombotic autoantibodies such as those targeting angiotensin II type I receptor (AT1R-Ab). <h4>Methods</h4> We compared prevalence and levels of AT1R-Ab in COVID-19 cases with mild or severe disease to age and sex matched negative controls utilizing multivariate logistic and quantile regression adjusted for comorbidities including hypertension, diabetes, and heart disease. <h4>Results</h4> There were trends toward increased prevalence (50% vs. 33%, p = 0.1) and level of AT1R-Ab (median 9.8 vs. 6.1 U/mL, p = 0.06) in all cases versus controls. When considered by COVID-19 disease severity, there was a trend toward increased prevalence of AT1R-Ab (55% vs. 31%, p = 0.07), as well as significantly higher AT1R-Ab levels (median 10.7 vs. 5.9 U/mL, p = 0.03) amongst individuals with mild COVID-19 versus matched controls. In contrast, the prevalence (42% vs. 37%, p = 0.9) and level (both medians 6.7 U/mL, p = 0.9) of AT1R-Ab amongst those with severe COVID-19 did not differ from matched controls. <h4>Conclusions</h4> These findings support an association between COVID-19 and AT1R-Ab, emphasizing that vascular pathology may be present in individuals with mild COVID-19 as well as those with severe disease.Yonghou JiangFergal DuffyJennifer HadlockAndrew RaappanaSheila StyrchakIngrid BeckFred D. MastLeslie R. MillerWilliam ChourJohn HouckBlair ArmisteadVenkata R. DuvvuriWinnie YeungMicaela HaglundJackson WallnerJulie A. WallickSamantha HardyAlyssa OldroydDaisy KoAna GervassiKim M. MurrayHenry KaplanJohn D. AitchisonJames R. HeathD. Noah SatherJason D. GoldmanLisa FrenkelWhitney E. HarringtonPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 11 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Yonghou Jiang Fergal Duffy Jennifer Hadlock Andrew Raappana Sheila Styrchak Ingrid Beck Fred D. Mast Leslie R. Miller William Chour John Houck Blair Armistead Venkata R. Duvvuri Winnie Yeung Micaela Haglund Jackson Wallner Julie A. Wallick Samantha Hardy Alyssa Oldroyd Daisy Ko Ana Gervassi Kim M. Murray Henry Kaplan John D. Aitchison James R. Heath D. Noah Sather Jason D. Goldman Lisa Frenkel Whitney E. Harrington Angiotensin II receptor I auto-antibodies following SARS-CoV-2 infection
description	<h4>Background</h4> Coronavirus disease 2019 (COVID-19) is associated with endothelial activation and coagulopathy, which may be related to pre-existing or infection-induced pro-thrombotic autoantibodies such as those targeting angiotensin II type I receptor (AT1R-Ab). <h4>Methods</h4> We compared prevalence and levels of AT1R-Ab in COVID-19 cases with mild or severe disease to age and sex matched negative controls utilizing multivariate logistic and quantile regression adjusted for comorbidities including hypertension, diabetes, and heart disease. <h4>Results</h4> There were trends toward increased prevalence (50% vs. 33%, p = 0.1) and level of AT1R-Ab (median 9.8 vs. 6.1 U/mL, p = 0.06) in all cases versus controls. When considered by COVID-19 disease severity, there was a trend toward increased prevalence of AT1R-Ab (55% vs. 31%, p = 0.07), as well as significantly higher AT1R-Ab levels (median 10.7 vs. 5.9 U/mL, p = 0.03) amongst individuals with mild COVID-19 versus matched controls. In contrast, the prevalence (42% vs. 37%, p = 0.9) and level (both medians 6.7 U/mL, p = 0.9) of AT1R-Ab amongst those with severe COVID-19 did not differ from matched controls. <h4>Conclusions</h4> These findings support an association between COVID-19 and AT1R-Ab, emphasizing that vascular pathology may be present in individuals with mild COVID-19 as well as those with severe disease.
format	article
author	Yonghou Jiang Fergal Duffy Jennifer Hadlock Andrew Raappana Sheila Styrchak Ingrid Beck Fred D. Mast Leslie R. Miller William Chour John Houck Blair Armistead Venkata R. Duvvuri Winnie Yeung Micaela Haglund Jackson Wallner Julie A. Wallick Samantha Hardy Alyssa Oldroyd Daisy Ko Ana Gervassi Kim M. Murray Henry Kaplan John D. Aitchison James R. Heath D. Noah Sather Jason D. Goldman Lisa Frenkel Whitney E. Harrington
author_facet	Yonghou Jiang Fergal Duffy Jennifer Hadlock Andrew Raappana Sheila Styrchak Ingrid Beck Fred D. Mast Leslie R. Miller William Chour John Houck Blair Armistead Venkata R. Duvvuri Winnie Yeung Micaela Haglund Jackson Wallner Julie A. Wallick Samantha Hardy Alyssa Oldroyd Daisy Ko Ana Gervassi Kim M. Murray Henry Kaplan John D. Aitchison James R. Heath D. Noah Sather Jason D. Goldman Lisa Frenkel Whitney E. Harrington
author_sort	Yonghou Jiang
title	Angiotensin II receptor I auto-antibodies following SARS-CoV-2 infection
title_short	Angiotensin II receptor I auto-antibodies following SARS-CoV-2 infection
title_full	Angiotensin II receptor I auto-antibodies following SARS-CoV-2 infection
title_fullStr	Angiotensin II receptor I auto-antibodies following SARS-CoV-2 infection
title_full_unstemmed	Angiotensin II receptor I auto-antibodies following SARS-CoV-2 infection
title_sort	angiotensin ii receptor i auto-antibodies following sars-cov-2 infection
publisher	Public Library of Science (PLoS)
publishDate	2021
url	https://doaj.org/article/cd573774925a43b6bf26a92fa1b1734f
work_keys_str_mv	AT yonghoujiang angiotensiniireceptoriautoantibodiesfollowingsarscov2infection AT fergalduffy angiotensiniireceptoriautoantibodiesfollowingsarscov2infection AT jenniferhadlock angiotensiniireceptoriautoantibodiesfollowingsarscov2infection AT andrewraappana angiotensiniireceptoriautoantibodiesfollowingsarscov2infection AT sheilastyrchak angiotensiniireceptoriautoantibodiesfollowingsarscov2infection AT ingridbeck angiotensiniireceptoriautoantibodiesfollowingsarscov2infection AT freddmast angiotensiniireceptoriautoantibodiesfollowingsarscov2infection AT lesliermiller angiotensiniireceptoriautoantibodiesfollowingsarscov2infection AT williamchour angiotensiniireceptoriautoantibodiesfollowingsarscov2infection AT johnhouck angiotensiniireceptoriautoantibodiesfollowingsarscov2infection AT blairarmistead angiotensiniireceptoriautoantibodiesfollowingsarscov2infection AT venkatarduvvuri angiotensiniireceptoriautoantibodiesfollowingsarscov2infection AT winnieyeung angiotensiniireceptoriautoantibodiesfollowingsarscov2infection AT micaelahaglund angiotensiniireceptoriautoantibodiesfollowingsarscov2infection AT jacksonwallner angiotensiniireceptoriautoantibodiesfollowingsarscov2infection AT julieawallick angiotensiniireceptoriautoantibodiesfollowingsarscov2infection AT samanthahardy angiotensiniireceptoriautoantibodiesfollowingsarscov2infection AT alyssaoldroyd angiotensiniireceptoriautoantibodiesfollowingsarscov2infection AT daisyko angiotensiniireceptoriautoantibodiesfollowingsarscov2infection AT anagervassi angiotensiniireceptoriautoantibodiesfollowingsarscov2infection AT kimmmurray angiotensiniireceptoriautoantibodiesfollowingsarscov2infection AT henrykaplan angiotensiniireceptoriautoantibodiesfollowingsarscov2infection AT johndaitchison angiotensiniireceptoriautoantibodiesfollowingsarscov2infection AT jamesrheath angiotensiniireceptoriautoantibodiesfollowingsarscov2infection AT dnoahsather angiotensiniireceptoriautoantibodiesfollowingsarscov2infection AT jasondgoldman angiotensiniireceptoriautoantibodiesfollowingsarscov2infection AT lisafrenkel angiotensiniireceptoriautoantibodiesfollowingsarscov2infection AT whitneyeharrington angiotensiniireceptoriautoantibodiesfollowingsarscov2infection
_version_	1718413893100896256

Angiotensin II receptor I auto-antibodies following SARS-CoV-2 infection

Ejemplares similares